Letal, a tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells

Cancer Biology and Therapy

Volumn 2, Issue 4, 2003, Pages 446-451

  Conejo Garcia, Jose R ^a   Benencia, Fabian ^a   Courreges, Maria C ^a   Khang, Eugene ^a   Zhang, Lin ^a   Mohamed Hadley, Alisha ^a   Vinocur, Jeffrey M ^a   Buckanovich, Ronald J ^a   Thompson, Craig B ^a   Levine, Bruce ^a   Coukos, George ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cultured; Cytotoxicity; Ligands; Membrane proteins; Neoplasms; Tumor cells

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 2; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; NATURAL KILLER CELL ACTIVATING RECEPTORS; PHOSPHOLIPASE C; RETINOIC ACID;

AMINO ACID SEQUENCE; ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL STRAIN K 562; COLON TUMOR; CYTOTOXICITY; DRUG EFFECT; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; MOUSE; NATURAL KILLER CELL; OVARY TUMOR; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; COLONIC NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; K562 CELLS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PHOSPHOLIPASE C; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TRETINOIN;

EID: 1542433160     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.2.4.479     Document Type: Article

References (26)

1. Yee C, Greenberg P. Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses. Nat Rev Cancer 2002; 2:409-19. (Pubitemid 37328938)
2. Pardoll DM. Immunology. Stress, NK receptors, and immune surveillance. Science 2001; 294:534-6.
3. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285:727-9.
4. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001; 2:255-60. (Pubitemid 33706003)
5. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001; 413:165-71. (Pubitemid 32867877)
6. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002; 17:19-29. (Pubitemid 34874615)
7. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 1998; 391:703-7. (Pubitemid 28113218)
8. Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999; 285:730-2.
9. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001; 14:123-33. (Pubitemid 32206515)
10. Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA 2001; 98:11521-6. (Pubitemid 32928761)
11. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, et al. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001; 294:605-9. (Pubitemid 32999559)
12. Combet C, Blanchet C, Geourjon C, Deleage G. NPS@: network protein sequence analysis. Trends Biochem Sci 2000; 25:147-50. (Pubitemid 30122428)
13. Solovyev VV, Salamov AA. INFOGENE: a database of known gene structures and predicted genes and proteins in sequences of genome sequencing projects. Nucleic Acids Res 1999; 27:248-50. (Pubitemid 29209451)
14. Milanesi L, D'Angelo D, Rogozin IB. GeneBuilder: interactive in silico prediction of gene structure. Bioinformatics 1999; 15:612-21. (Pubitemid 29462110)
15. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1997;10:1-6.
16. Pasquier C, Promponas VJ, Palaios GA, Hamodrakas JS, Hamodrakas SJ. A novel method for predicting transmembrane segments in proteins based on a statistical analysis of the SwissProt database: the PRED-TMR algorithm. Protein Eng 1999;12:381-5. (Pubitemid 29265394)
17. Rost B, Sander C. Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol 1993; 232:584-99. (Pubitemid 23251181)
18. Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K, et al. Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. Faseb J 2001;15:1819-21.
19. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348:203-13. (Pubitemid 36077915)
20. Maus MV, Thomas AK, Leonard DG, Allman D, Addya K, Schlienger K, et al. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB. Nat Biotechnol 2002; 20:143-8. (Pubitemid 34158029)
21. Radosavljevic M, Cuillerier B, Wilson MJ, Clement O, Wicker S, Gilfillan S, et al. A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics 2002; 79:114-23.
22. Carayannopoulos LN, Naidenko OV, Fremont DH, Yokoyama WM. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol 2002; 169:4079-83. (Pubitemid 35178173)
23. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000; 12:721-7.
24. Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, Spies T, et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer 2003; 104:354-61. (Pubitemid 36249818)
25. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419:734-8. (Pubitemid 35177960)
26. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002; 298:850-4. (Pubitemid 35231542)